(Q39733926)

14 September 2017

T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract (English)

1 reference

14 September 2017

Binfeng Lu

1

1 reference

14 September 2017

Lujun Chen

2

1 reference

14 September 2017

Lin Liu

3

1 reference

14 September 2017

Yibei Zhu

4

1 reference

14 September 2017

Changping Wu

5

1 reference

14 September 2017

Jingting Jiang

6

1 reference

14 September 2017

Xueguang Zhang

7

1 reference

14 September 2017

1 August 2011

1 reference

14 September 2017

1 reference

14 September 2017

50

1 reference

14 September 2017

2-3

1 reference

14 September 2017

269-275

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-011-8227-9

14 September 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

An expert opinion on esophageal cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Costimulatory and coinhibitory receptors in anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

The B7 family and cancer therapy: costimulation and coinhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Inhibitory costimulation and anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Immune resistance orchestrated by the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Gadd45b and Gadd45g are important for anti-tumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

T-bet and eomesodermin are required for T cell-mediated antitumor immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Trawling for treasure: tales of T-bet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

T-bet plays a key role in NK-mediated control of melanoma metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

In vivo tumor suppression activity by T cell-specific T-bet restoration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

CXCR3 ligands: redundant, collaborative and antagonistic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

T(H)17 cells in tumour immunity and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

PD-1 signaling in primary T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Features of responding T cells in cancer and chronic infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

CD8 T cell dysfunction during chronic viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

B7S1, a novel B7 family member that negatively regulates T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

B7x: a widely expressed B7 family member that inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Generation and characterization of B7-H4/B7S1/B7x-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

B7-H4-deficient mice display augmented neutrophil-mediated innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Regulation of cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

The CD28 signaling pathway regulates glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-011-8227-9

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance

21 January 2018

1 reference

12 December 2020

Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer

1 reference

12 December 2020

Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo

1 reference

12 December 2020

B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S12026-011-8227-9

Identifiers

DOI

1 reference

14 September 2017

1 reference